Human neuronal cell-based models of AD can also be employed to evaluate potential therapeutic effects of the novel AD strategies, such as, for example, the depletion of iAβ by its targeted degradation via the activation of BACE1 and/or BACE2. The gene discussed is BACE1; the disease is Alzheimer disease.